Showing results (191-200 of 330) with videos related to
Sort By:
Pageof 33
Cancer Discovery|September 27, 2018
Exploiting MCL1 Dependency with Combination MEK + MCL1 Inhibitors Leads to Induction of Apoptosis and Tumor Regression in KRAS-Mutant Non-Small Cell Lung CancerVaruna Nangia, Faria M Siddiqui, Sean Caenepeel, et al.Lung Cancer (Amsterdam, Netherlands)|November 16, 2018
Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 studyShirish M Gadgeel, James P Stevenson, Corey J Langer, et al.The Lancet. Oncology|June 9, 2015
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6James C-H Yang, Lecia V Sequist, Sarayut Lucien Geater, et al.The New England Journal of Medicine|April 30, 2015
Rociletinib in EGFR-mutated non-small-cell lung cancerLecia V Sequist, Jean-Charles Soria, Jonathan W Goldman, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 13, 2013
Detection of impaired homologous recombination repair in NSCLC cells and tissuesMoritz Birkelbach, Natalie Ferraiolo, Liliana Gheorghiu, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2011
Randomized phase II study of erlotinib plus tivantinib versus erlotinib plus placebo in previously treated non-small-cell lung cancerLecia V Sequist, Joachim von Pawel, Edward G Garmey, et al.Blood|September 1, 2005
Autologous and allogeneic stem cell transplantations for poor-risk chronic lymphocytic leukemiaJohn G Gribben, David Zahrieh, Katherine Stephans, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 11, 2012
A phase I study of erlotinib and hydroxychloroquine in advanced non-small-cell lung cancerSarah B Goldberg, Jeffrey G Supko, Joel W Neal, et al.JTO Clinical and Research Reports|July 31, 2023
B-Cell Infiltrate in the Tumor Microenvironment Is Associated With Improved Survival in Resected Lung AdenocarcinomaIbiayi Dagogo-Jack, Ivan Valiev, Nikita Kotlov, et al.Cancer Discovery|May 16, 2012
Amplification of CRKL induces transformation and epidermal growth factor receptor inhibitor resistance in human non-small cell lung cancersHihu Wing Cheung, Jinyan Du, Jesse S Boehm, et al.Pageof 33